Neurocrine Biosciences, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.07%152.580.0%$1908.49m
OCGNOcugen, Inc. -3.31%8.330.0%$1009.27m
BNTXBioNTech SE -2.85%180.830.0%$830.99m
AMGNAmgen, Inc. 0.99%253.301.3%$722.53m
SNSSSunesis Pharmaceuticals, Inc. -7.07%8.540.7%$596.98m
NVAXNovavax, Inc. -0.95%126.6079.8%$560.30m
GILDGilead Sciences, Inc. 1.32%68.341.0%$495.12m
REGNRegeneron Pharmaceuticals, Inc. 1.68%515.682.7%$418.88m
ALXNAlexion Pharmaceuticals, Inc. 1.05%173.792.0%$415.84m
VRTXVertex Pharmaceuticals, Inc. 0.19%213.091.9%$311.26m
ILMNIllumina, Inc. -0.52%370.903.5%$293.73m
BIIBBiogen, Inc. 2.16%279.941.7%$262.43m
VXRTVaxart, Inc. -1.05%6.440.0%$232.74m
CRSPCRISPR Therapeutics AG -0.44%100.400.6%$161.33m
SGENSeagen Inc. -0.11%144.625.8%$137.43m

Company Profile

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.